These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 20653455)

  • 21. [Efficacy and safety of the single pill combination of valsartan 80 mg plus amlodipine 5 mg in mild to moderate essential hypertensive patients without adequate blood pressure control by monotherapy].
    Ke YN; Huang J; Zhu JR;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):794-9. PubMed ID: 20128376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
    Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
    Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; Domínguez MJ; Covelo M; Fernández JR; Mojón A; López JE
    Hypertension; 2003 Sep; 42(3):283-90. PubMed ID: 12874091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
    Hermida RC; Ríos MT; Crespo JJ; Moyá A; Domínguez-Sardiña M; Otero A; Sánchez JJ; Mojón A; Fernández JR; Ayala DE;
    Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients.
    Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M
    J Hum Hypertens; 2006 Oct; 20(10):787-94. PubMed ID: 16810279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial combination therapy with amlodipine/valsartan compared with monotherapy in the treatment of hypertension.
    Philipp T; Glazer RD; Wernsing M; Yen J
    J Am Soc Hypertens; 2011; 5(5):417-24. PubMed ID: 21592879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of the combination valsartan/hydrochlorothiazide compared with amlodipine in a mild-to-moderately hypertensive Brazilian population.
    Franco RJ; Goldflus S; McQuitty M; Oigman W;
    Blood Press Suppl; 2003 Dec; 2():41-7. PubMed ID: 14761076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE
    Hypertension; 2005 Oct; 46(4):960-8. PubMed ID: 16144987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation.
    Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH; Fabbian F; Portaluppi F
    Chronobiol Int; 2013 Mar; 30(1-2):280-314. PubMed ID: 23077971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability.
    Ulusoy S; Ozkan G; Konca C; Kaynar K
    Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
    Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
    Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine.
    Asmar R; Gosse P; Queré S; Achouba A
    Blood Press Monit; 2011 Apr; 16(2):80-6. PubMed ID: 21372694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.